ACADIA HEALTHCARE COMPANY INC

NASDAQ: ACHC (Acadia Healthcare Company, Inc.)

Last update: 15 hours ago

13.86

0.37 (2.74%)

  • 1D 2.74%
  • 5D 1.32%
  • 1M 4.76%
  • 6M -27.32%
  • YTD -3.01%
  • 1Y -66.98%
  • 5Y -73.94%
Previous Close 13.49
Open 13.64
Volume 748,484
Avg. Volume (3M) 3,314,160
Market Cap 1,253,557,504
Price / Earnings (TTM) 11.95
Price / Earnings (Forward) 6.66
Price / Sales 0.380
Price / Book 0.400
52 Weeks Range
11.43 (-17%) — 42.96 (209%)
Earnings Date 25 Feb 2026
Profit Margin 5.94%
Operating Margin (TTM) 10.19%
Diluted EPS (TTM) 2.04
Quarterly Revenue Growth (YOY) 0.30%
Quarterly Earnings Growth (YOY) -89.00%
Total Debt/Equity (MRQ) 74.09%
Current Ratio (MRQ) 1.35
Operating Cash Flow (TTM) 462.46 M
Levered Free Cash Flow (TTM) -276.20 M
Return on Assets (TTM) 5.06%
Return on Equity (TTM) 6.33%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (US) Bullish Mixed
Medical Care Facilities (Global) Bullish Bullish
Stock Acadia Healthcare Company, Inc. Bearish Bearish

AIStockmoo Score

-0.8
Analyst Consensus -0.5
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages -2.5
Technical Oscillators -0.5
Average -0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ACHC 1 B - 11.95 0.400
HCSG 1 B - 35.63 2.69
PIII 1 B - - 0.620
INNV 794 M - - 4.09
CCRN 262 M - - 0.750
TOI 255 M - - 0.760

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Value
% Held by Insiders 1.75%
% Held by Institutions 109.93%

Ownership

Name Date Shares Held
Khrom Capital Management Llc 30 Sep 2025 5,037,448
Abrams Bison Investments, Llc 30 Sep 2025 4,380,000
Sachem Head Capital Management Lp 30 Sep 2025 4,215,000
Maverick Capital Ltd 30 Sep 2025 3,006,505
P2 Capital Partners, Llc 30 Sep 2025 2,337,188
52 Weeks Range
11.43 (-17%) — 42.96 (209%)
Price Target Range
13.00 (-6%) — 25.00 (80%)
High 25.00 (Keybanc, 80.38%) Buy
Median 17.00 (22.66%)
Low 13.00 (B of A Securities, -6.21%) Sell
Average 18.00 (29.87%)
Total 5 Buy, 5 Hold, 1 Sell
Avg. Price @ Call 14.16
Firm Date Target Price Call Price @ Call
Jefferies 22 Jan 2026 15.00 (8.23%) Hold 15.15
TD Cowen 16 Jan 2026 22.00 (58.73%) Buy 11.68
RBC Capital 14 Jan 2026 17.00 (22.66%) Buy 11.73
03 Dec 2025 19.00 (37.09%) Buy 14.69
Mizuho 18 Dec 2025 17.00 (22.66%) Hold 14.43
Barclays 04 Dec 2025 14.00 (1.01%) Hold 14.64
B of A Securities 03 Dec 2025 13.00 (-6.20%) Sell 14.69
Cantor Fitzgerald 03 Dec 2025 17.00 (22.66%) Hold 14.69
Deutsche Bank 03 Dec 2025 20.00 (44.30%) Buy 14.69
Keybanc 03 Dec 2025 25.00 (80.38%) Buy 14.69
18 Nov 2025 30.00 (116.45%) Buy 15.01
Leerink Partners 03 Dec 2025 14.00 (1.01%) Hold 14.69
UBS 03 Dec 2025 24.00 (73.16%) Buy 14.69
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria